United States · FDA National Drug Code directory
IRBESARTAN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62332-041_e21c14f4-6c8c-4676-b479-dff181ec3fa1
- Product NDC
- 62332-041
- Form
- TABLET
- Composition / generic term
- IRBESARTAN
- Labeler
- Alembic Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20160701
- Source listing expiry
- 20261231
Source-listed ingredients
- IRBESARTAN — 75 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (62332-041-30) · 62332-041-30
- 100 TABLET in 1 BOTTLE (62332-041-31) · 62332-041-31
- 500 TABLET in 1 BOTTLE (62332-041-71) · 62332-041-71
- 90 TABLET in 1 BOTTLE (62332-041-90) · 62332-041-90
- 1000 TABLET in 1 BOTTLE (62332-041-91) · 62332-041-91
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →